We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Opponents, Advocates Battle Over Proposed Generic Labeling Rule
Opponents, Advocates Battle Over Proposed Generic Labeling Rule
Drugmakers sparred with consumer and patient advocates at a March 27 public hearing on the FDA’s proposed rule to give generics makers the ability to update label safety information independently — with generics firms opposing the rule and advocacy groups supporting it.